International Business News - REGN http://www.ibtimes.com All articles are copyrighted by IBTimes.com 400 100 http://www.ibtimes.com/ http://www.ibtimes.com/images/top_logo_ibt2_3.gif Regeneron Pharmaceuticals said Wednesday its drug Arcalyst showed positive results at treating the painful inflammatory disease gout in midstage trials. http://www.ibtimes.com/articles/20080903/regeneron-reports-positive-results-from-gout-study.htm Wed, 03 Sep 2008 13:03:55 EDT Regeneron Pharmaceuticals Inc. and Bayer HealthCare AG said Tuesday their drug candidate VEGF Trap-Eye continued to benefit patients with macular degeneration, which can lead to blindness, after one year of use in a clinical trial. http://www.ibtimes.com/articles/20080819/regeneron-and-bayer-report-follow-up-eye-drug-data.htm Tue, 19 Aug 2008 09:03:56 EDT Among the stock activity stories for Friday, June 6, from AP Financial News: NEW YORK (AP)--Shares of specialty contact lens maker Cooper Cos. fell Friday, despite posting fiscal second-quarter profit in line with Wall Street expectations and reaffirming its fiscal 2008 profit and revenue outlook, after analysts expressed concern about competitive pressures and free cash flow. http://www.ibtimes.com/articles/20080606/movers-roundup-cooper-tumbleweed.htm Fri, 06 Jun 2008 14:56:18 EDT A Lehman Brothers analyst said Regeneron Pharmaceuticals Inc.'s cancer drug aflibercept compares more favorably with Genentech Inc.'s Avastin than investors realize. http://www.ibtimes.com/articles/20080606/analyst-says-regeneron-oversold-on-drug-failure.htm Fri, 06 Jun 2008 17:11:44 EDT The Standard & Poor's SmallCap 600 Index advanced on Thursday, led by Hot Topic Inc. after the teen apparel retailer said its May same-store sales fell less than expected. http://www.ibtimes.com/articles/20080605/s-p-smallcap-600-in-focus-hott-regn.htm Thu, 05 Jun 2008 13:55:06 EDT As growth slows in shares of large-cap biotechs and economic woes weigh on the broader markets, investors can find dramatic growth opportunities in many small and midcap biotechs who have secured lucrative research and development partnerships. http://www.ibtimes.com/articles/20080521/partnerships-drive-big-stock-gains-for-small-biotechs.htm Wed, 21 May 2008 16:58:51 EDT Shares of biopharmaceutical company Regeneron Pharmaceuticals Inc. fell sharply Wednesday after the company reported that a mid-stage trial of an ovarian cancer drug in development missed its goal. http://www.ibtimes.com/articles/20080521/regeneron-shares-slide-on-missed-cancer-study-goal.htm Wed, 21 May 2008 16:46:39 EDT The Standard & Poor's SmallCap 600 Index edged higher on Wednesday, led by shares of Central Garden & Pet Co. after a Piper Jaffray analyst upgraded the company in a note to investors. http://www.ibtimes.com/articles/20080521/s-p-smallcap-600-in-focus-centa-regn.htm Wed, 21 May 2008 13:54:28 EDT A mid-stage study of an advanced ovarian cancer drug under development by Sanofi-Aventis and Regeneron Pharmaceuticals Inc. failed to meet its goal, the companies said Wednesday. http://www.ibtimes.com/articles/20080521/sanofi-aventis-regeneron-cancer-drug-misses-goal.htm Wed, 21 May 2008 08:08:56 EDT Shares of Regeneron Pharmaceuticals Inc. spiked nearly 8 percent Thursday, after the biopharmaceutical company reported a much smaller quarterly loss than Wall Street expected. http://www.ibtimes.com/articles/20080501/last-call-regeneron-spikes-on-earnings-report.htm Thu, 01 May 2008 15:50:01 EDT